Preview Mode Links will not work in preview mode

CoI’Q with Dr. Roxie is a first-of-its-kind interactive video show, where top health innovators, early adopters, and influencers speak candidly about the peaks, valleys, and wild ride of commercializing healthcare innovations.

Many people will launch a new product, but few will commercialize it. On CoI'Q, you'll learn the difference between launch and commercialization, so you can circumvent failure, accelerate customer adoption, and optimize market success! Brought to you by Legacy DNA, a healthcare marketing firm.

Jun 7, 2019

When it comes to commercializing breakthrough innovations, how you position yourself in the category and the ability to find the right partners are key. How can you fund new innovations and overcome physician adoption challenges? How do you get the top healthcare leaders to support the innovation? What are some of the elements that can become barriers to market success?

 On this episode, I’m joined by health tech investor, digital health innovator, and health systems operator, Sarah Sossong. She is one of Fierce Health’s “influential women reshaping health IT”, and she pioneered large-scale innovations from concept to mass adoption and national recognition. On this show, Sarah shares her insights and advice to healthcare innovators.

 

3 Things We Learned

  • Language and messaging are key in the mass adoption of innovations
  • Focusing more on the technology and not the problem you’re trying to solve affects your innovation
  • How to make it easier for a physician to adopt your innovation

There are many barriers to the adoption of innovation, and many of them can be mitigated by laying the right groundwork, and taking the right steps. Leadership buy-in, leveraging internal champions, and starting with a problem not a technology are some of the ways you can ensure the success of your innovation. Whatever you do, think long-term. Don’t just think about what you’re doing right now, think about the parts of the innovation that are the most scalable beyond the present moment or the pilot phase.